WS #13488
Holding: newest synthesis is 96d 20h old
Eli Lilly reports Q2 revenue +48% and EPS $8.38 vs $6.01 est., raises FY guidance and price target to $1,300, reinforcing GLP-1 leadership.
Eli Lilly Beat-and-Raise
Eli Lilly reports Q2 revenue +48% and EPS $8.38 vs $6.01 est., raises FY guidance and price target to $1,300, reinforcing GLP-1 leadership.